|
RELIEF FROM CHRONIC PAIN WHEN
RESOURCES ARE LIMITED.
Rajagopal M.R, Pain and Palliative Care Clinic,
Medical College, Calicut 673008, Kerala, India.
The Indian health care scene has a curious mix
of paradoxes. Advances in Cardiovascular surgery or high-tech investigative
facilities in India are on par with any advanced country at least in some
cities. But across the road from a high tech hospital, it will be easy
to find hundreds denied of primary health care. Pain relief is a case
in point. At least a million people in India suffer unrelieved cancer
pain. The number of people suffering other chronic pain conditions is
anyone’s guess. India is not alone. The situation is common to
most of the developing world.
For any medical advance to occur, the initiative
has to come from either the professionals or from the executive. Neither
happens in the field of pain. Unlike high-tech medicine, pain treatment
lacks glamour. So it does not attract the professional. The executive
does not consider this a priority. Control of infectious diseases is a
priority item; pain control is not.
But it should be. The extent of suffering
in the community is enormous. And unnecessary. Most of chronic pain can
be effectively treated by simple measures. And it is up to us professionals
to point this out to the administrators and to generate some interest.
For
this, the first requirement is that pain relief centres should be able
to demonstrate efficacy and cost effectiveness. Unfortunately, even interested
professionals or institutions often lack a sense of direction. Many professionals
attempt to treat pain single- handedly, employing those treatment modalities
with which they are most familiar and in which they are most skilled.
The anaesthetist uses nerve blocks, the acupuncturist attempts to treat
every pain with acupuncture and the physiatrist relies on physical measures
alone. This approach is doomed to fail.
The hardest part in pain treatment is that it
requires multi- disciplinary approach. In an ideal world, every specialist’s
opinion should be pooled with those of the nurse and the psychologist,
and the perfect treatment decided on, of course with the involvement of
the patient and the relatives. But this theoretical ideal can never be
reached. Several professionals sitting around one table to look after
a patient is a Utopian dream which can never be practiced, considering
how busy professionals are.
The answer is for the pain therapist to understand
the importance of the multidisciplinary approach. He must be prepared
to take on the role of the general practitioner and to look at the problem
from the patient’s point of view. He will have to assess the pain
and the degree of emotional involvement in the pain experience and then
consider various therapeutic options. And when necessary seek the help
of other specialists.
Management of Pain
Assessment of pain need be no more difficult
in the developing world than in more advanced countries, because (with
some exceptions) evaluation is clinical. What is needed is only the expertise
- the ability to distinguish between a nociceptive pain and a neuropathic
pain, for example. It is also important to remember the concept of total
pain: pain is not just a sensation. It is “ a
sensory and emotional experience ”
1 .
Physical pain will
inevitably be modified by social, emotional and
spiritual factors. Therefore attempts to treat chronic pain only as a
physical entity are bound to be ineffective. Every pain therapist will
need to learn the fundamentals of counseling and communication skills.
And the patient must be believed about the pain. “ Pain
is what the patient says, hurts ”
2 .
The World Health Organisation (WHO) analgesic
ladder
The World Health Organisation (WHO) Three-step
Analgesic Ladder 3
(Figure 1) has revolutionized treatment
of cancer pain
all over the world. It involves the use of oral
drug therapy by the clock, depending on the duration of action of the
drug. In step I, non-opioids like paracetamol or NSAIDs are used. When
they are inadequate to control pain, weak opioids like codeine or dextro-propoxyphene
are added. If this fails to control the pain, the weak opioid is stopped
and a strong opioid like morphine is substituted. The most important principle
in practicing the ladder are:
● Give
drugs by mouth
whenever possible. Injections are impractical in the long term and add
to discomfort.
● Allergic
manifestations, including bronchospasm, which is uncommon with oral therapy.
As these drugs are usually effective only if
given round the clock, the following recommendations for the frequency
of administration may be helpful.
● Give
the drugs by the clock
depending on the duration of action of each individual drug.
Step 1
For a mild pain of the obvious nociceptive nature,
it is amazing how much benefit a simple drug like paracetamol can give
if used by the clock - say, 4-6hourly. No other analgesic has less of
side effects; and it is quite safe to use it in the long term even in
doses as high as 4-6g/day. Even if it is not enough to give a reasonable
degree of pain relief, it can reduce the dose of more potent drugs.
Most non-steroidal anti-inflammatory drugs (NSAIDs)
are used
in the long term by mouth to treat cancer pain.
They can be used safely if we remember the most important side-effects
namely,
● Gastritis
(If this happens, a concurrent H 2
blocker may be needed).
● Platelet
dysfunction
● Possibility
of renal failure in the patient who is predisposed to it.
| Drug
|
Frequency
in hours |
Aspirin
Ibuprofen
Diclofenac
Ketorolac
Some COX-2 selective
NSAIDs are relatively inexpensive in India
Meloxicam
Rofecoxib |
4-6
hourly
6-8 hourly
8-12 hourly
6-8 hourly
24 hourly
24 hourly |
Step II
If step I by itself is inadequate to control
the pain, step II involves the addition of a weak opioid. The commonly
available drugs in India, the recommended dose and the required frequency
of administration are:
| Drug
|
Frequency
in hours |
| Codeine
30 - 60mg |
4
hourly |
| Dextropropoxyphene
65mg |
6-8
hourly |
| (This
is usually available |
|
| only
in combination with |
|
| paracetamol).
|
|
| Tramadol
50-100mg |
6-8
hourly |
| Buprenorphine
|
6-8
hourly |
| (0.2-0.4mg
sublingual) |
|
| (Many
would include |
|
| buprenorphine
among |
|
| strong
opioids) |
|
Dextropropoxyphene is the least expensive among
the lot. Tramadol is more potent; but expensive. Pentazocine is available
for oral use, but is not recommended because it causes dysphoria and has
too short a duration of action 4
. Weak opioids have a special
place in our country because of limited availability
of oral morphine. But unfortunately they all seem to have a ceiling effect.
This means that their dose can be increased only up to a point. This limits
their use in severe pain.
Step III
When step II drugs are inadequate to treat pain,
step III involves continuing the step I drugs, stopping the weak opioids
and adding a strong opioid.
Oral morphine
is the mainstay of treatment of severe cancer pain. Contrary to popular
belief, oral morphine (when used for opioid-sensitive pain, with dose
titrated to the degree of pain relief) does
not cause addiction or respiratory depression 4
.
An overdose causes side effects like drowsiness,
delirium and myoclonus, which serve as warning signs.
The usual starting dose is 5-10mg. As required,
the dose is increased by 50% every 1-2 days, till the desired effect is
reached. The following are the common side effects:
● Constipation
can be troublesome, and almost all patients on opioids require laxatives.
The choice in this case would be a stimulant laxative like bisacodyl or
senna. It can be usefully combined with a softener/lubricant like docusate
or liquid paraffin.
● Up to
one third of patients get vomiting in the first few days of therapy and
require anti-emetics.
● Up to
one third of patients feel tired especially in the first few days of therapy.
A few may also have anorexia.
● Urinary
hesitancy is a relatively rare side effect.
● A few
may have pruritus. This usually disappears with a few days of anithistaminics.
Bypassing steps I and II
Pain clinics in India being few and far between,
we often see patients in long-standing excruciating pain. The concept
of WHO analgesic ladder, obviously, needs to be modified in such pain
emergencies. One possibility is to use titrated intravenous bolus doses
of 1.5mg of morphine every ten minutes till eventually the patient either
gets pain relief or becomes drowsy 5
. If the patient
gets drowsy while still in pain, it indicates
that the patient has at least some opioid-insensitive pain. An alternative
in cancer pain emergencies is to start the patient on 10mg oral morphine
every hour till pain relief is achieved 6
. The point to be emphasised here
is that in severe cancer pain, there is a case
for bypassing the first two steps of the ladder.
Availability of oral morphine
India has the paradoxical situation of supplying
the rest of the world with opium for medical purposes, while our own patients
are denied pain relief. Stringent and unrealistic narcotic regulations
are responsible for this situation. Efforts are under way to simplify
narcotic regulations. Seven states in India now
have simplified narcotic regulations that make
availability of oral morphine easier 7
. A complicated licensing system is necessary
in the other states.
Adjuvant Analgesics in Opioid-Resistant Pain
Adjuvant analgesics are drugs that have no analgesic
action per se, but in a particular context confer pain relief. Not all
pains respond to opioids. Some of them respond only partially. Administration
of morphine to such a patient will make him more miserable by causing
drowsiness, tiredness, delirium or myoclonus. The following types of pains
are examples of relatively opioid-resistant pains.
● Muscular
pains . (Should be treated by muscle
relaxants and injection of myofascial trigger points in some cases).
● Colicky
pain . (This responds to antispasmodics
like hyoscine butylbromide or dicyclomine).
● Bone
pain . (Here, opioids need to be combined
with NSAIDs, and in some cases, with corticosteroids).
● Pain
in constipation .
● Neuropathic
pain .
General Principles of Management of Neuropathic
Pain
The mainstay in the treatment of neuropathic
pain is the use of two groups of drugs, anticonvulsants
and antidepressants 8
.
Either could be the first-line drug. Antidepressants
are better tolerated and for many centers, they form the first line drug.
When one alone fails, combinations of the two might work. Usual doses
of these drugs are:
Anticonvulsants
Carbamazepine
Phenytoin
Sodium valproate |
200
- 400 mg 8 hourly
200 - 400 mg daily
Up to 1200 mg nocte. |
Tricyclic
antidepressants
Amitryptilene
Doxepin |
25
- 75 mg at bed-time
25 - 75 mg at bed-time |
As they all cause significant side effects, the
starting dose should
be low, and the dose should be increased gradually.
And side effects should be looked for and treated.
Anticonvulsants act by membrane stabilization.
It is possible that sodium valproate also works by GABA enhancement
4 .
Tricyclic
antidepressants act on the descending inhibitory
pathways by preventing re-uptake of serotonin and norepinephrine and thus
increasing the concentration of these inhibitory neurotransmitters at
the synapses.
When these two first-line drugs are inadequate
to control neuropathic pain, there are several other options. One is the
oral administration of local anaesthetic agents like mexiletine
. An intravenous dose of lignocaine
, 1mg/Kg can be used as a therapeutic trial. If
it succeeds in achieving analgesia for more than 20 minutes (a short-lived
analgesia could be because of placebo effect) then the patient can be
started on oral mexiletine on a regular basis 9
.
Ketamine
hydrochloride, an anaesthetic agent that acts on the NMDA receptor also
has been successfully used orally in the relief of intractable neuropathic
pain 10 .
It can be started in a dose
of 0.5mg/Kg six-hourly, and gradually increased.
However, there can be significant side effects like delirium and hallucinations.
Amantidine ,
an anti-parkinsonism drug, also has been shown to cause NMDA -antagonism
and has been seen to be of help in nerve injury type of pain. It is used
in doses of 50 - 100mg daily 11
.
Corticosteroids
are of particular value in nerve compression pain and in pain of elevated
intracranial tension.They may be administered systemically, but when feasible,
local drug delivery (such as epidural) has advantages. Dexamethasone is
the preferred agent for systemic administration and triamcinolone for
epidural injection.
Some local measures can be of help. When there
is significant cutaneous hyperalgesia, a topical agent like capsaicin
may help. When there is accessible normal nerve
proximal to the lesion, Transcutaneous
Electrical Nerve Stimulation (TENS)
can be helpful. Repeated stellate ganglion
local anaesthetic blocks are recommended
for complex regional pain syndrome (CRPS) of the upper limb.
When oral drug therapy fails, central measures
like continuous epidural analgesia
or neurolytic procedures may be indicated.
Coeliac plexus blockade in upper abdominal malignancy is an example. These
have particular relevance when the patient comes from too far away for
review and for titration of drug doses. When facilities like image intensifier
are unavailable, other practical solutions may have to be sought, like
thoracic epidural alcohol injection for pain of thoracic and upper abdominal
malignancy 12
.
General Principles of Pain Management
The following general principles may be useful
for people who venture to the field of pain relief.
● Identification
of the type of pain is key to successful treatment of pain. Therapeutic
modalities to be followed in neuropathic pain, say, are significantly
different from those needed in bone pain.
● Remember
that any pain, if long-standing, can become centrally established. Neural
tissue can develop anatomical and even genetic alterations. Once a pain
is centrally established, peripheral attempts at treating them (like peripheral
nerve blocks) are bound to be ineffective
● Somatisation:
When negative feelings like fear or anger are brought out as physical
symptoms like pain, it is called “somatisation”. It is common
for doctors to feel irritated about it. But we should remember that somatisation
is not the patient’s fault. There may be emotional reasons behind
the pain. It is up to the doctor to identify it and to deal with it.
● While
a particular intervention like a nerve block may have its relevance in
a particular case, drug therapy is usually the ideal basic therapeutic
modality in a large number of patients.
● The
obviously perfect form of therapy (from the physician’s point of
view) may be totally unsuitable if it is unaffordable to the patient.
The patient’s financial status must be taken into consideration
when planning treatment.
Development of a Pain Relief Service
Any attempt at solving the pain problem in a
poor country has to take into account the enormity of numbers and should
be realistic. We find that about 80% of patients approaching a pain clinic
have cancer pain 13
. Two parallel services have developed
in the
West - the pain clinics run mostly by anaesthetists
and the ‘hospice’ or palliative care service. Neither is
well established in India or in most of developing world. Much of the
needs are common in both services, and perhaps an integration of both
services is the most practical solution for us.
When we developed a palliative care unit in Calicut
14
we based it
on the following principles.
● The
patients’ needs should come first .
This may sound obvious; but does not often get practiced. We need to remind
ourselves that our efforts can succeed only if the management is based
on what the patient needs for improved quality of life.
● The
care delivery system should be realistic .
It has to suit the local cultural and economic background
● Doctors
need to establish a partnership in care with the family .
The strength in India is in the strong family structure. Empowering relatives
to care for the patient can achieve a lot.
● A
partnership in care also needs to be established with the patient
. The average villager is quite capable of making
brave and intelligent decisions regarding treatment options. Formal education
and intelligence are not synonymous. Doctors have no right to force decisions
on the patient.
● We
have to make use of existing resources .
India has the advantage of a network of primary, secondary and tertiary
health care centers. These have their advantages and their drawbacks.
We need to use whatever the existing machinery has to offer. If we don’t,
we will end up spending too much.
● Deficiencies
in existing facilities need to be supplemented by NGOs .
We must find ways to supplement all shortcomings in the available machinery.
If non-Government organizations (NGOs) can work with the Government machinery,
it could prove to be of benefit to the patient.
● Willing
volunteers can be the backbone of the facility .
There are numerous individuals who are kind hearted and are willing to
help. This strong work force only needs to be organized and channeled
properly.
The Calicut Experience
In Calicut, a small city in the South Indian
state of Kerala, we have developed an organisation that could be represented
with the patient at the apex, the relatives and the volunteers next to
them and the medical system supporting them. The medical system in this
case involves both the Government machinery and an NGO 14
. A clinic works in the Government Medical
College
Hospital, supported by The Pain and Palliative
Care Society, a registered charitable organisation with its headquarters
at Calicut.
It finds and trains volunteers and provides essential
staff, equipment, and drugs wherever the Government machinery falls short.
The system, over the last eight years, has grown
to reach an average of 2000 patients a year in the parent clinic at Calicut.
Daily patient attendance now averages 60 and the clinic sees an average
of 100 - 130 new patients a month. We work with local doctors and NGOs
to establish peripheral centers in neighboring districts. 27 such clinics
are operative now in the various parts of Kerala. In some of them there
are also home visit programmes to look after those who are too sick to
travel to a clinic 15
. We now
estimate that 15% of the needy in Kerala have
access to pain relief and palliative care.
While it is true that a lot has been achieved
in eight years, there are still a million more in India in need of pain
relief. To reach out and to ease them, we do not need a lot of expensive
gadgetry or sophistication. Morphine manufactured in India out of poppy
already grown in India, a few other not-too-expensive drugs, and the realization
among administrators and professionals that freedom from pain is a human
right, are all that are needed.
References
1. IASP Sub-committee on Taxonomy. Pain terms:
a list with definitions and notes on usage. Pain
. 1980; 8
:249-52.
2. Black RG. The Chronic Pain Syndrome.
Surgical Clinics of North America
. 1975; 55
:999-1011.
3. World Health Organisation. Cancer Pain Relief.
WHO. 1986.
4. Twycross R. Introducing Palliative Care. Radcliffe
Medical Press. Oxford. 1999.
5. Sureshkumar K, Rajagopal MR, Naseema AM. Intravenous
morphine for emergency treatment of cancer pain. Palliative
Medicine. 2000;14:183-8.
6. Expert Working Group of the European Association
for Palliative Care. Morphine in cancer pain: modes of administration.
British Medical Journal
. 1996; 312
:823-26.
7. Rajagopal MR, Joranson DE, Gilson AM. Medical
use, misuse and diversion of opioids in India. The
Lancet . 2001; 358
:139-43
8. Woodruff R. Palliative Medicine: Symptomatic
and Supportive Care for Patients with Advanced Cancer and AIDS. Oxford
University Press, Melbourne. 1999.
9. Kalso E, Tramer HJ, McQuay et al. Systemic
local-anaesthetic-type drugs in chronic pain: a systematic review.
European Journal of Pain .
1998; 2 :3-14.
10. Fisher K, Coderre TJ, Hagen NA et al. Targeting
the N-Methyl-DAspartate Receptor for Chronic Pain Management: Preclinical
Animal Studies, Recent Clinical Experience and Future Research Directions.
Journal of Pain Symptom Management
. 2000;5:358-73.
11. Pud D, Eisenberg E, Spitzer A et al. The
NMDA receptor antagonist amantadine reduces surgical neuropathic pain
in cancer patients: a double blind, randomized, placebo controlled trial.
Pain .
1998;75:349-354
12. Korevaar WC. Transcatheter epidural neurolysis
using ethyl alcohol. Anesthesiology
. 1988; 69
:989-93.
13. Sureshkumar R, Rajagopal MR. Palliative Care
in Kerala. Problems at Presentation in 440 patients with advanced cancer
in a South Indian state. Palliative
Medicine . 1996; 10
:293-8
14. Rajagopal M R, Sureshkumar. A model for delivery
of palliative care in India - The Calicut Experiment. Journal
of Palliative Care . 1999; 15
:44-9
15. Ajithakumari K, Sureshkumar K, Rajagopal
M R. Palliative Home Care - The Calicut Experiment. Palliative
Medicine. 1997; 11
:451-4
Address for correspondence: Professor of Anaesthesiology,
Pain and Palliative Care Clinic, Medical College Calicut 673008, Kerala,
India., Telephone: 009 1495 359157, Fax: 009 1495 354897, E-mail:mrraj5@sify.com,
Web-site: www. painpalliative.org This article
on Chronic Pain Management in Difficult Situations was commissioned by
the WFSA Committee on Pain Relief for publication in Update in Anaesthesia.
Dr Rajagopal is part of a team that started with minimal resources and
built an excellent pain and palliative care centre, which is now recognised
by WHO as a role model for developing countries and utilised by WHO as
their training centre.
|